MACROCYCLIC BLOCKERS FOR USE IN THE REDUCTION OF PERIPHERAL SIDE EFFECTS DUE TO EVEROLIMUS THERAPY
WO2026060005A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name MONTARA THERAPEUTICS, INC..
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
WO2026060005A1 · Application publication visible